InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-16.2%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Parsons James T., Director. Officer active across 1 company, notably DiaMedica Therapeutics Inc.. Cumulatively, 4 filings have been published. Activity tracked since 3 January 2022. The latest transaction was disclosed on 21 November 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
12,000 shares@ US$2.20Common StockSEC:0001759855-25-000006:0
15,917 shares@ US$5.3433.9% of flowVoting Common Shares, no par value per shareSEC:0001235802-25-000005:0
21,428 shares@ US$2.8022.5% of flowVoting Common Shares, no par value per shareSEC:0001235802-24-000002:0
16,773 shares@ US$3.580.013% mcap50.0% of flowVoting Common Shares, no par value per shareSEC:0001235802-22-000002:0
4 of 4 declarations
About Parsons James T.
James T. Parsons is a Director at DiaMedica Therapeutics Inc. As a board member, he participates in overseeing the company's operations and making strategic decisions. James brings significant expertise in the biopharmaceutical sector, allowing him to contribute to the growth and profitability of DiaMedica. His commitment to corporate governance ensures strong and responsible leadership.
